ANTX - Wall Street Estimates - AN2 Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 1.27

0 %

$ 37.9 M

Market Cap

-0.64

P/E

Price Target Average

241.21%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

23.67%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets AN2 Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for ANTX of $4.33 , with forecasts ranging from a low of $2 to a high of $6 .

ANTX Lowest Price Target Wall Street Target

2 USD 57.48%

ANTX Average Price Target Wall Street Target

4.33 USD 241.21%

ANTX Highest Price Target Wall Street Target

6 USD 372.44%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free